Clinical Trials Logo
  1. Home
  2. Cardiovascular Disease
  3. NCT01629238
  4. Details
NCT01629238 Clinical Trial

Characteristics of Plant Sterols Consumers in France

Cardiovascular Disease Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01629238
Other study ID # NU333
Secondary ID
Status Completed
Phase N/A
First received June 25, 2012
Last updated October 7, 2016
Start date October 2010
Est. completion date April 2012

Study information
Verified date October 2016
Source Danone Research
Contact n/a
Is FDA regulated No
Health authority France : The Commission nationale de l'informatique et des libertés (CNIL)France : Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé (CCTIRS)France: Ministère de l'Enseignement supérieur et de la RechercheFrance: Conseil National de l'Ordre des Médecins
Study type Observational

Clinical Trial Summary

The purpose of this study is to describe the cardiovascular risk profile in subjects who consume a marketed drinkable low fat fermented milk enriched with plant sterol. Investigations are lead prospectively and retrospectively among adults enrolled from general practitioners' database.

Recruitment information / eligibility
Status Completed
Enrollment 780
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- male and female aged 18-70 years, regular visits to GP (at least once every six months within the past 2 years), agreeing to a written informed consent

Exclusion Criteria:

- any clinical, psychological or language problem that would prevent from completing the questionaires or communicating with GP

Study Design

N/A

Related Conditions & MeSH terms

Locations
Country Name City State
France BKL Consultant Boulogne-Billancourt

Sponsors (1)
Lead Sponsor Collaborator
Danone Research

Country where clinical trial is conducted

France, 

See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Completed NCT02502812 - Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects Phase 1
Recruiting NCT04216342 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers Phase 1
Completed NCT03654313 - Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Phase 1
Completed NCT03646656 - Heart Health Buddies: Peer Support to Decrease CVD Risk N/A
Completed NCT02081066 - Identification of CETP as a Marker of Atherosclerosis N/A
Completed NCT02147626 - Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Recruiting NCT03095261 - Incentives in Cardiac Rehabilitation N/A
Completed NCT02998918 - Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL N/A
Completed NCT02711878 - Healing Hearts and Mending Minds in Older Adults Living With HIV N/A
Completed NCT02589769 - Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons N/A
Not yet recruiting NCT02578355 - National Plaque Registry and Database N/A
Completed NCT02868710 - Individual Variability to Aerobic Exercise Training N/A
Recruiting NCT02885792 - Coronary Artery Disease in Patients Suffering From Schizophrenia N/A
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Completed NCT02272946 - Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Phase 2
Completed NCT02640859 - Investigation of Metabolic Risk in Korean Adults
Completed NCT02657382 - Mental Stress Ischemia: Biofeedback Study N/A
Recruiting NCT02265250 - Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment